Physician profile
Christopher W Arnold
NPI 1396751574
$4,598.76
in general payments reported to CMS, 2019-2025
19 companies · $865 in 2025
The $865 reported for 2025 was more than what 89% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $807 · 2020: $513 · 2021: $556 · 2022: $456 · 2023: $664 · 2024: $737 · 2025: $865.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,246 · Entertainment: $19.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,246.46 |
| Entertainment | $19.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,433.60 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $680.32 | 2022-2025 | Infuse, Miebo, Xiidra |
| Alcon Vision LLC | $569.10 | 2019-2025 | Precision 7, Precision7, Dailies |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $468.28 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $257.43 | 2019-2025 | Cequa |
| Coopervision INC. | $254.02 | 2022-2025 | Clariti Contact Lens, Myday Contact Lens, Misight Contact Lens |
| Tarsus Pharmaceuticals, INC. | $218.19 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $186.66 | 2022-2025 | Tyrvaya |
| Glaukos Corporation | $165.27 | 2020-2021 | |
| Allergan, INC. | $78.44 | 2020-2021 | |
| Maculogix, INC. | $56.00 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $47.29 | 2020-2022 | |
| Astellas Pharma US INC | $40.68 | 2024 | Izervay |
| Optos, INC. | $39.54 | 2019-2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Abbvie INC. | $33.03 | 2022-2023 | Vuity, Alphagan P, Lumigan |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lkc Technologies, INC. | $22.59 | 2025 | |
| Kala Pharmaceuticals, INC. | $19.67 | 2021 | |
| Abb Con-Cise Optical Group LLC | $19.50 | 2019 | |
| Biotissue Holdings INC. | $9.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Arnold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.